(Q83049542)
Statements
Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension (English)
Andreas Reiff
Daniel J Lovell
Janet Van Adelsberg
Maria H B Kiss
Steven Goodman
Manuel Ferrandiz Zavaler
Pei-Yun Chen
James A Bolognese
Paul Cavanaugh
Alise S Reicin
Edward H Giannini